8-K
Current Report
Aldeyra Therapeutics, Inc. Filed Acc 0001193125-16-447637
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading d128528d8k.htm…